Page last updated: 2024-11-06

prosulfuron

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Prosulfuron is a sulfonylurea herbicide used to control broadleaf weeds in various crops. It is synthesized through a multi-step process involving the reaction of 2-chloro-4-trifluoromethylpyrimidine with 4-chloro-2-(trifluoromethyl)benzenesulfonamide. Prosulfuron works by inhibiting the enzyme acetolactate synthase (ALS), which is essential for amino acid biosynthesis in plants. This disruption leads to the death of susceptible weeds. Prosulfuron is highly effective in controlling a wide range of weeds, including annual grasses, broadleaf weeds, and sedges. It is also known for its long-lasting residual activity, providing extended weed control. Prosulfuron is widely studied due to its environmental persistence and potential for off-target effects. Studies focus on its fate and transport in the environment, its impact on non-target organisms, and the development of resistant weed populations. Understanding these aspects is crucial for optimizing its use and minimizing potential risks.'

prosulfuron: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91751
CHEMBL ID2251587
CHEBI ID8523
SCHEMBL ID56036
MeSH IDM0430013

Synonyms (36)

Synonym
AC-18025
LS-14390
prosulfuron [iso]
benzenesulfonamide, n-(((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)-2-(3,3,3-trifluoropropyl)-
prosulfuron
94125-34-5
NCGC00163833-01
n-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-2-(3,3,3-trifluoropropyl)benzenesulfonamide
NCGC00163833-02
NCGC00163833-03
NCGC00163833-04
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenyl]sulfonylurea
hsdb 8445
ng7le47j14 ,
unii-ng7le47j14
FT-0642262
AKOS015900032
n-(((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)-2-(3,3,3-trifluoropropyl)benzenesulfonamide
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-(2-(3,3,3-trifluoropropyl)phenylsulfonyl)urea
peak
prosulfuron [mi]
cga-152005
SCHEMBL56036
chebi:8523 ,
CHEMBL2251587
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenyl]sulfonyl-urea
n-[2-(3,3,3-trifluoropropyl)-phenylsulfonyl]-n'-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-urea
DTXSID9034868
prosulfuron, pestanal(r), analytical standard
n-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoyl)-2-(3,3,3-trifluoropropyl)benzenesulfonamide
Q22808801
benzenesulfonamide,n-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]-2-(3,3,3-trifluoropropyl)-
E78749
A916750
CS-W021019
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triazinesCompounds based on a triazine skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.42 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index50.58 (26.88)
Search Engine Supply Index2.44 (0.95)

This Compound (35.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]